Andrea Villanueva Raisman, PhD student at KTH Royal Institute of Technology and SciLifeLab, presents her poster "Multi-platform linking of the plasma proteome across abundance scales enables a novel framework for capturing disease biology."..Read more

At HUPO 2026 in Singapore, Loren Méar presented research investigating how the tumor microenvironment may contribute to chemotherapy response in high-grade serous ovarian cancer...Read more

Breast cancer is the most common cancer among women worldwide with more than 2 million new cases diagnosed each year. The cancer develops in the mammary gland with the most common forms being adenocarcinomas arising from the epithelial cells that line the milk ducts or the milk-producing lobules. Among these invasive ductal carcinoma (IDC) is the most common type and accounts for around 80% of the cases...Read more

T cells are central drivers of inflammation across autoimmune and inflammatory diseases, yet current therapies inadequately target pathogenic T-cell pathways, limiting durable disease control. In a recent study published in Signal Transduction and Targeted Therapy, a team led by Thomas Helleday and Theodora Manolakou, identified a novel, targetable transcriptional-metabolic axis that sustains inflammatory T-cell responses. In an interview by Gustav Ceder, Helleday discusses the novel findings and ongoing lines of research...Read more

In this episode of Proteins Unfolded Evelina Sjöstedt, head of Single cell analysis at the Human Protein Atlas, joins the hosts PhD students Andrea Villanueva Raisman and Emilio Skarwan to explore the transcriptome, the bridge between our static DNA and active proteins...Read more